Inhibrx Biosciences, Inc. (INBX) — Working Capital to Net Assets Ratio
Inhibrx Biosciences, Inc. (INBX) has a Working Capital to Net Assets ratio of -688.5% as of March 2026. Working capital of $144.83 Million (current assets of $171.34 Million minus current liabilities of $26.51 Million) is measured against net assets of $-21.04 Million. A higher ratio indicates strong short-term liquidity financed by the equity base. See how many days can Inhibrx Biosciences, Inc. fund operations to measure how many days the company can operate on defensive assets alone.
WC/NA Ratio
Working Capital
Current Assets
Current Liabilities
Inhibrx Biosciences, Inc. Working Capital to Net Assets (2016–2025)
This chart shows how Inhibrx Biosciences, Inc.'s Working Capital to Net Assets ratio has evolved across 10 annual periods from 2016 to 2025. As of March 2026, the ratio stands at -688.5%, reflecting working capital of $144.83 Million against net assets of $-21.04 Million USD. For the complete balance sheet picture, see Inhibrx Biosciences, Inc. (INBX) total assets.
Annual Working Capital to Net Assets for Inhibrx Biosciences, Inc. (2016–2025)
The table below presents the year-by-year Working Capital to Net Assets ratio for Inhibrx Biosciences, Inc. from 2016 to 2025, covering 10 annual filings. Each row shows current assets, current liabilities, working capital, net assets, the ratio, and the change in percentage points compared to the prior year. Read Inhibrx Biosciences, Inc. total liabilities for a breakdown of total debt and financial obligations.
| Year | WC/NA Ratio | Working Capital (USD) | Net Assets | Current Assets | Current Liabilities | Change (pp) |
|---|---|---|---|---|---|---|
| 2025 | 1239.0% | $99.03 Million | $7.99 Million | $132.83 Million | $33.80 Million | ▲ +1149.4 pp |
| 2024 | 89.6% | $119.67 Million | $133.58 Million | $160.40 Million | $40.73 Million | ▼ -459.9 pp |
| 2023 | 549.5% | $239.05 Million | $43.50 Million | $295.36 Million | $56.31 Million | ▲ +113.9 pp |
| 2022 | 435.6% | $252.92 Million | $58.06 Million | $280.49 Million | $27.58 Million | ▲ +212.9 pp |
| 2021 | 222.7% | $116.66 Million | $52.38 Million | $139.11 Million | $22.45 Million | ▲ +89.2 pp |
| 2020 | 133.5% | $100.77 Million | $75.47 Million | $132.17 Million | $31.40 Million | ▲ +128.2 pp |
| 2019 | 5.4% | $-5.01 Million | $-93.57 Million | $15.56 Million | $20.57 Million | ▼ -12.9 pp |
| 2018 | 18.3% | $-10.53 Million | $-57.64 Million | $5.66 Million | $16.18 Million | ▲ +47.3 pp |
| 2017 | -29.1% | $6.52 Million | $-22.42 Million | $15.44 Million | $8.92 Million | ▼ -1250.1 pp |
| 2016 | 1221.0% | $15.13 Million | $1.24 Million | $20.41 Million | $5.28 Million | — |